Literature DB >> 24293330

Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.

Marco Sandri1, Luisa Coletto, Paolo Grumati, Paolo Bonaldo.   

Abstract

A number of recent studies have highlighted the importance of autophagy and the ubiquitin-proteasome in the pathogenesis of muscle wasting in different types of inherited muscle disorders. Autophagy is crucial for the removal of dysfunctional organelles and protein aggregates, whereas the ubiquitin-proteasome is important for the quality control of proteins. Post-mitotic tissues, such as skeletal muscle, are particularly susceptible to aged or dysfunctional organelles and aggregation-prone proteins. Therefore, these degradation systems need to be carefully regulated in muscles. Indeed, excessive or defective activity of the autophagy lysosome or ubiquitin-proteasome leads to detrimental effects on muscle homeostasis. A growing number of studies link abnormalities in the regulation of these two pathways to myofiber degeneration and muscle weakness. Understanding the pathogenic role of these degradative systems in each inherited muscle disorder might provide novel therapeutic targets to counteract muscle wasting. In this Commentary, we will discuss the current view on the role of autophagy lysosome and ubiquitin-proteasome in the pathogenesis of myopathies and muscular dystrophies, and how alteration of these degradative systems contribute to muscle wasting in inherited muscle disorders. We will also discuss how modulating autophagy and proteasome might represent a promising strategy for counteracting muscle loss in different diseases.

Entities:  

Keywords:  Autophagy; Duchenne; Dystrophy; Muscle wasting; Myopathy; Skeletal muscle

Mesh:

Substances:

Year:  2013        PMID: 24293330     DOI: 10.1242/jcs.114041

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  85 in total

1.  Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.

Authors:  Utkarsh J Dang; Michael Ziemba; Paula R Clemens; Yetrib Hathout; Laurie S Conklin; Eric P Hoffman
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

2.  Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle.

Authors:  Jennifer L Steiner; Kristen T Crowell; Scot R Kimball; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

3.  What Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle?

Authors:  Dirk Pette
Journal:  Eur J Transl Myol       Date:  2017-06-24

Review 4.  TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Neurobiol Dis       Date:  2018-05-28       Impact factor: 5.996

5.  Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice.

Authors:  Chia-Shan Wu; Qiong Wei; Hongying Wang; Da Mi Kim; Miriam Balderas; Guoyao Wu; John Lawler; Stephen Safe; Shaodong Guo; Sridevi Devaraj; Zheng Chen; Yuxiang Sun
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

6.  Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.

Authors:  James B Papizan; Alexander H Vidal; Svetlana Bezprozvannaya; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Biol Chem       Date:  2018-04-13       Impact factor: 5.157

7.  In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells.

Authors:  Francesco Castagnetti; Elisabetta Fiacco; Carol Imbriano; Lucia Latella
Journal:  J Vis Exp       Date:  2017-06-12       Impact factor: 1.355

8.  Therapeutic Benefit of Autophagy Modulation in Pompe Disease.

Authors:  Jeong-A Lim; Baodong Sun; Rosa Puertollano; Nina Raben
Journal:  Mol Ther       Date:  2018-05-03       Impact factor: 11.454

9.  Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.

Authors:  Fabio Arturo Iannotti; Ester Pagano; Aniello Schiano Moriello; Filomena Grazia Alvino; Nicolina Cristina Sorrentino; Luca D'Orsi; Elisabetta Gazzerro; Raffaele Capasso; Elvira De Leonibus; Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2018-09-09       Impact factor: 8.739

Review 10.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.